About ABLE
|
|||||||||||||||
 |
|||||||||||||||
| Member Information | |||||||||||||||
|
|||||||||||||||
Indian Scenario
|
|||||||||||||||
|
|||||||||||||||
| Events | |||||||||||||||
|
|||||||||||||||
| Contact | |
|
|
Evolution of the Biotech Sector in India
|
Indian Biotechnology has had an interesting evolution that started with strands of activity on various academic and industry fronts which are now intertwined to provide a strong interface between industry and academia. The future of Indian Biotechnology will henceforth follow the format of academia, generating intellectual capital for commercialization by industry. It is envisaged that this will stimulate scientists to pursue entrepreneurial aspirations. The following is a chronology of key events that have shaped the Indian Biotech sector: |
|
| Milestones: The first decade | |
| 1978 | BANGALORE: The country's first biotech company BIOCON is established - for industrial enzymes and later biotherapeutics. |
| 1981 | HYDERABAD: Center for Cellular & Molecular Biology (CCMB) - for DNA & r-DNA based research. |
| 1984 | CHANDIGARH: Institute for Microbial Technology, (IMTECH) - for R&D in microbial bio-processing. |
| 1986 | NEW DELHI: Department of Biotechnology (DBT), set up by Government of India - for promoting modern biology and biotechnology at academic and industry levels. |
| 1987 | NEW DELHI: National Institute of Immunology (NII) set up by DBT - for immunology research. |
| 1989 | BANGALORE: BANGALORE GENEI starts operations - to produce restriction enzymes & other tools for DNA based R&D. |
| Milestones: The second decade | |
| 1991 | BANGALORE: National Center for Biological Sciences (NCBS) - to pursue R&D in molecular biology. |
| 1994 | BANGALORE: Syngene International, country's first CRC (promoted by Biocon) - to offer R&D services in drug discovery based modern biology. |
| 1997 | NEW DELHI: Center for Biochemical Technology (CBT) - to focus on Bioinformatics and Genomics. |
| 1997 | HYDERABAD: Shantha Biotech launches India's first recombinant product, Hep B vaccine. |
| 1998 | BANGALORE: Monsanto research establishes an R&D center at IISc for plant genomics. |
| 1998 | NEW DELHI: DBT approves Mahyco-Monsanto to conduct Bt cotton trials. |
| 1999 | BANGALORE: NCBS scientist sets up AVESTHAGEN a plant genomics company. |
| Milestones: The third decade | |
| 2000 | 4 states Andhra Pradesh, Karnataka, Maharashtra and Tamil Nadu announce Biotech initiatives. |
| 2000 | BANGALORE: Country's first Bio informatics company Strand Genomics formed by four IISc professors. |
| 2000 | NEW DELHI: GENOMED country's first JV between Institute (CBT) & Industry (Nicholas Piramal) - to pursue pharmaco-genomics. |
| 2001 | Reliance sets up Reliance Life Sciences to pursue stem cell based research and product development. |
| 2001 | MUMBAI: GEAC approves Wockhardt's EPO. |
| 2001 | NIH approves NCBS and Reliance Life Sciences as 2 out of 10 labs worldwide, for stem cell lines. |
| 2001 | Drug Authority implements GCP guidelines for clinical trials. |
| 2001 | Millennium biotech policy, the first state level Biotech policy, announced by Government of Karnataka. |
| 2002 | BANGALORE: Institute of Bioinformatics & Applied Biotechnology, IBAB, a jointly funded initiative between the Government of Karnataka & ICICI commences academic program. |
| 2002 | GEAC approves Bt cotton for commercial planting. |
| 2002 | HYDERABAD: GEAC approves Shantha Biotech's Inteferon Alpha 2b. |
| HUMAN RESOURCE PROFILE: 700,000 POST GRADUATES + 1500 PhDs | |
|
||
 |